Carrie Hersh, DO, MSc: Addressing Progressive Disease in MS
The assistant professor of neurology at the Lerner College of Medicine and neurologist at Luo Ruvo Center for Brain Health, both of Cleveland Clinic, spoke to the importance of preventing progression in MS and treating the non-inflammatory aspects of the disease.
By: Carrie Hersh, DO, MSc
Published: March 07, 2020
“While we have demonstrated that early highly effective therapies in MS are key to forestalling early inflammatory disease activity that later prevents progression and disability accumulation later on, there is still quite a knowledge gap in terms of how we treat non-lesional activity.”
Many specialists in multiple sclerosis (MS), including Carrie Hersh, DO, MSc, assistant professor of neurology, Lerner College of Medicine, and neurologist, Luo Ruvo Center for Brain Health, Cleveland Clinic, have expressed their excitement about the modern landscape of MS treatment. With multiple options available and a solid base of understanding for treatment plans, physicians have never been better positioned to treat their patients.